$1.76
0.021.15%
At close: -
$1.55
-0.21-11.93%
After Hours: Dec 20, 7:08 AM EDT
Comments
Loading...
Latest news for Protalix BioTherapeutics (AMEX:PLX) Stock
Protalix BioTherapeutics Stock (AMEX: PLX)
Categories: All
Monday, December 09, 2024
Thursday, November 14, 2024
Wednesday, November 13, 2024
Friday, October 25, 2024
Tuesday, September 03, 2024
Wednesday, August 14, 2024
Friday, May 17, 2024
Friday, May 10, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
Tuesday, November 14, 2023
Monday, November 06, 2023
Friday, November 03, 2023
Tuesday, October 31, 2023
Monday, October 23, 2023
Monday, October 09, 2023
Tuesday, September 12, 2023
Tuesday, August 08, 2023
Monday, August 07, 2023
Friday, August 04, 2023
Tuesday, May 23, 2023
Thursday, May 18, 2023
Wednesday, May 10, 2023
Friday, May 05, 2023
Thursday, May 04, 2023
- Protalix Clocks 40% Decline In Q1 Revenues Reflecting Lower Sales To Brazil
- Protalix Biotherapeutics And Chiesi Global Rare Diseases Get European Commission Approval Of Elfabrio (Pegunigalsidase Alfa) For The Treatment Of Fabry Disease
- Protalix BioTherapeutics Q1 EPS $(0.05), Same...
- Earnings Scheduled For May 4, 2023
Tuesday, February 28, 2023
Monday, February 27, 2023
- Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
- Protalix Biotherapeutics Entered Into An At The Market Offering Agreement With H.C. Wainwright Under Which Protalix May Sell From Time To Time Common Stock Having An Aggregate Offering Price Of Up To $20M
- Protalix BioTherapeutics FY EPS $(0.31) Beats...
- Earnings Scheduled For February 27, 2023